{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:38:57Z","timestamp":1791920337983,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009950","name":"MOE","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009950","id-type":"DOI","asserted-by":"publisher"}]},{"name":"HEC-NRPU project","award":["5291\/Federal\/NRPU\/R&D\/HEC\/2016"],"award-info":[{"award-number":["5291\/Federal\/NRPU\/R&D\/HEC\/2016"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ejmech.2019.01.062","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T15:43:22Z","timestamp":1548603802000},"page":"224-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Design, synthesis and anti-bacterial studies of piperazine derivatives against drug resistant bacteria"],"prefix":"10.1016","volume":"166","author":[{"given":"Saba","family":"Tahir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiqa","family":"Dastgir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihsan-ul","family":"Haq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Waseem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2419-3172","authenticated-orcid":false,"given":"Umer","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.01.062_bib1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(15)00474-2","article-title":"Access to effective antimicrobials: a worldwide challenge","volume":"387","author":"Laxminarayan","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2019.01.062_bib2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1126\/science.aad9358","article-title":"Antibiotic use and its consequences for the normal microbiome","volume":"352","author":"Blaser","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.01.062_bib3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mib.2017.05.014","article-title":"Next-generation precision antimicrobials: towards personalized treatment of infectious diseases","volume":"37","author":"Fuente-Nunez","year":"2017","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejmech.2019.01.062_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001502","article-title":"Risk of early-onset neonatal infection with maternal infection or colonization: a global systematic review and meta-analysis","volume":"10","author":"Chan","year":"2013","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejmech.2019.01.062_bib5","first-page":"1","article-title":"Antimicrobial drugs in fighting against antimicrobial resistance","volume":"7","author":"Guyue","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2019.01.062_bib6","first-page":"e1403","article-title":"A\u00a0Review on Antibiotic Resistance: alarm bells are ringing","volume":"9","author":"Zaman","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.ejmech.2019.01.062_bib7","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/533452","article-title":"Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE","volume":"197","author":"Rice","year":"2008","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.01.062_bib8","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1086\/655995","article-title":"Progress and challenges in implementing the research on ESKAPE pathogens","volume":"31","author":"Rice","year":"2010","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"10.1016\/j.ejmech.2019.01.062_bib9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bjid.2017.03.006","article-title":"Resistance among Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Latin American countries: SMART 2013-2015","volume":"21","author":"Karlowsky","year":"2017","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.01.062_bib10","doi-asserted-by":"crossref","first-page":"1602308","DOI":"10.1183\/13993003.02308-2016","article-title":"World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update","volume":"49","author":"Falzon","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejmech.2019.01.062_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12913-017-2097-3","article-title":"Evaluation of rational drug use based on World Health Organization core drug use indicators in selected public hospitals of eastern Ethiopia: a cross sectional study","volume":"17","author":"Sisay","year":"2017","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.ejmech.2019.01.062_bib12","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1016\/j.bmc.2016.06.044","article-title":"A\u00a0Gestalt approach to Gram-negative entry","volume":"24","author":"Silver","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.062_bib13","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.bmc.2017.02.068","article-title":"Covalently linked kanamycin\u2013Ciprofloxacin hybrid antibiotics as a tool to fight bacterial resistance","volume":"25","author":"Shavit","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.062_bib14","doi-asserted-by":"crossref","first-page":"13381","DOI":"10.1021\/jp207013v","article-title":"Electroporation of the E.\u00a0coli and S.\u00a0aureus membranes: molecular dynamics simulations of complex bacterial membranes","volume":"115","author":"Piggot","year":"2011","journal-title":"J.\u00a0Phys. Chem. Biophys."},{"key":"10.1016\/j.ejmech.2019.01.062_bib15","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2174\/092986707780831168","article-title":"Dual action-based approaches to antibacterial agents","volume":"14","author":"Bremner","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.062_bib16","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2174\/1568026615666150915112459","article-title":"Short antimicrobial peptides and peptide scaffolds as promising antibacterial agents","volume":"16","author":"Domalaon","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.062_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00077-17","article-title":"Antibiotic hybrids: the next generation of agents and adjuvants against Gram-Negative Pathogens?","volume":"31","author":"Domalaon","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2019.01.062_bib18","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1016\/j.bmc.2014.05.018","article-title":"Novel 3-arylfuran-2 (5H)-one-fluoroquinolone hybrid: design, synthesis and evaluation as antibacterial agent","volume":"22","author":"Wang","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.062_bib19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejmech.2014.04.037","article-title":"Design, synthesis, and evaluation of novel fluoroquinolone\u2013flavonoid hybrids as potent antibiotics against drug-resistant microorganisms","volume":"80","author":"Xiao","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.062_bib20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejmech.2018.01.078","article-title":"Ciprofloxacin derivatives and their antibacterial activities","volume":"146","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.062_bib21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejmech.2017.12.089","article-title":"Amino acid conjugated antimicrobial drugs: synthesis, lipophilicity-activity relationship, antibacterial and urease inhibition activity","volume":"145","author":"Ullah","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.062_bib22","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1016\/j.bmcl.2016.10.051","article-title":"Design, synthesis, antibacterial activity and docking study of some new trimethoprim derivatives","volume":"26","author":"Rashid","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.01.062_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg212","article-title":"Development of the quinolones","volume":"51","author":"Monique","year":"2003","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2019.01.062_bib24","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2174\/092986707780831168","article-title":"Dual action-based approaches to antibacterial agents","volume":"14","author":"Bremner","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.062_bib25","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.bmcl.2016.03.062","article-title":"Synthesis and molecular modeling of antimicrobial active fluoroquinolone\u2013pyrazine conjugates with amino acid linkers","volume":"26","author":"Panda","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.01.062_bib26","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1021\/jm0510023","article-title":"Hybrid antibacterials. DNA polymerase-topoisomerase inhibitors","volume":"49","author":"Zhi","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.062_bib27","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.bmc.2005.10.032","article-title":"Synthesis and antimicrobial activity of N-alkyl and N-aryl piperazine derivatives","volume":"14","author":"Chaudhary","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.062_bib28","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.bmc.2013.12.017","article-title":"Gabapentin hybrid peptides and bioconjugates","volume":"22","author":"Lebedyeva","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.062_bib29","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.bmcl.2016.03.062","article-title":"Synthesis and molecular modeling of antimicrobial active fluoroquinolone\u2013pyrazine conjugates with amino acid linkers","volume":"26","author":"Panda","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419300819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419300819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T19:38:02Z","timestamp":1565206682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419300819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":29,"alternative-id":["S0223523419300819"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.01.062","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and anti-bacterial studies of piperazine derivatives against drug resistant bacteria","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.01.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}